Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sarepta Therapeutics buy melinda

Start price
€46.03
08.10.17 / 50%
Target price
€49.61
29.12.17
Performance (%)
11.09%
End price
€51.13
29.12.17
Summary
This prediction ended on 29.12.17 with a price of €51.13. The prediction had a final performance of 11.09%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Sarepta Therapeutics -1.409% -1.409% 10.865% 112.071%
iShares Core DAX® 4.094% 3.543% 17.404% 20.326%
iShares Nasdaq 100 1.424% 0.512% 39.212% 55.365%
iShares Nikkei 225® -1.572% -4.633% 15.731% 2.146%
iShares S&P 500 1.822% 0.963% 30.396% 45.950%

According to melinda what are the pros and cons of Sarepta Therapeutics for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Sarepta Therapeutics diskutieren
Prediction Buy
Perf. (%) 11.09%
Target price 49.610
Change
Ends at 29.12.17

Biotechnologie



Firmenprofil
Sarepta Therapeutics, Inc. ist ein biopharmazeutisches Unternehmen , das sich für die Entdeckung und Entwicklung von spezifischen Therapien an die RNA für die Behandlung von seltenen Krankheiten und andere infektiöse kümmert. Es konzentriert sich auf die Entwicklung ihrer Kandidaten für die DMD potenziell krankheitsmodifizierende. Die ...
lesen Sie mehr



Prediction Buy
Perf. (%) 11.09%
Target price 49.610
Change
Ends at 29.12.17

(Vom Mitglied beendet)

Stopped prediction by melinda for Sarepta Therapeutics

buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€131.66
02.11.18
€144.32
04.11.21
-52.21%
26.03.21

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€119.00
15.10.18
€135.30
02.11.18
10.17%
02.11.18

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€91.74
16.06.18
€94.71
19.06.18
57.31%
19.06.18

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€56.52
02.03.18
€84.79
08.03.18
17.79%
08.03.18

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€51.03
08.10.17
€55.00
29.12.17
11.09%
29.12.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€41.00
20.07.17
€45.00
21.07.17
1.24%
21.07.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€36.98
20.07.17
€40.59
21.07.17
1.24%
21.07.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€32.56
11.01.17
€88.40
28.04.17
2.91%
28.04.17

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€23.54
23.08.16
€24.81
24.08.16
5.36%
24.08.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€18.50
09.06.16
€19.84
08.07.16
8.82%
08.07.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€16.64
03.05.16
€18.04
23.05.16
8.57%
23.05.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€7.49
23.04.16
€16.24
03.05.16
120.49%
03.05.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€14.88
14.03.16
€18.04
21.03.16
22.62%
21.03.16

Could be worthwhile Investment >10% per year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€39.53
04.10.13
€41.00
04.04.14
-55.30%
04.04.14

Could be worthwhile Investment >10% per year